Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • articleNo Access

    BIOBOARD

      SINGAPORE – A*STAR Scientists Reveal How Stem Cells Defend Against Viruses: New Insights to the Mechanisms bring Broad Implications to Stem Cell Therapy and Disease Diagnosis

      SINGAPORE – Singtel - Singapore Cancer Society Race against Cancer 2015

      SINGAPORE – NCCS and IMCB to Collaborate on Research for New Treatments to Benefit Cancer Patients

      SINGAPORE – MerLion’s Finafloxacin Shown to be More Efficacious than Ciprofloxacin in the Treatment of Complicated Urinary Tract Infections

      TAIWAN AND UNITED STATES – Professor Yuk-ling Yung Receives Gerard P. Kuiper Prize

      SWEDEN – New Data Confirm Tresiba® U200 Delivers Significantly Lower Rates of Confirmed Hypoglycaemia versus Insulin Glargine U100

      UNITED KINGDOM – Using Ultrasound to Clean Medical Instruments

      THE NETHERLANDS & UNITED STATES – Philips and Dutch Radboud University Medical Centre Introduce First Diabetes Prototype App with Integrated Online Community to Empower Patients and Enhance Continuity of Care

      UNITED STATES – New Clinical Architecture Content Cloud Establishes Reliable Single Source for Terminology Updates, Makes It Easier to Keep Healthcare Systems Up-to-Date

      UNITED STATES – Genomic Analysis for All Cancer Patients

      UNITED STATES – Birds That Eat at Feeders Are More Likely to Get Sick, Spread Disease, International Research Team Says

    • articleNo Access

      INSIDE INDUSTRY

        BIOTRONIK Begins Manufacturing High-Tech Products in Singapore.

        First Dengue Vaccine Approved in More than 10 Countries.

        Zyrtec® Tablet for Allergy Relief, Now Available Over-the-Counter as Zyrtec®-R Tablet.

        Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running.

        First Pan-Asian Real-world Study on the Use of Rivaroxaban for Stroke Prevention in Patients with Atrial Fibrillation.

        Oxford Spinout to Develop Cancer Therapies which Reprogram Tumours to Die.

        Recruitment Begins for Major Clinical Study in Precision Therapy for Liver Cancer Patients.

        GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea.

      • articleNo Access

        FEATURES

          Cancer in Women – Trends in Singapore

          Impact of Subsidies on Genetic Testing Uptake in Singapore: Is it Feasible?

          The Future of Radiation Oncology

          Targeted Therapies in Oncology: Where We Are and What Lies Ahead

        • articleNo Access

          INSIDE INDUSTRY

            Drug development companies in APAC need to raise their game to capitalise on the $33bn+ immuno-oncology treatment opportunity

            Singapore’s pharmaceutical market value to reach $1.15 billion by 2021

            Ryzodeg reduces hypoglycaemia in type 2 diabetic fasting patients

            FDA approves Amgen’s Repatha (evolocumab) to prevent heart attack and stroke

            FDA approves first drug for rare disease, eosinophilic granulomatosis with polyangiitis

            FDA approves first biosimilar for the treatment of certain breast and stomach cancers

            FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss

            Singapore institutes collaborate with Samsung Medical Center to improve treatment of liver cancer

            Globavir announces partnership with Singhealth Duke-NUS Academic Medical Centre to study dengue treatment

            Mundipharma secures exclusive license for the development and commercialisation of PAION’s remimazolam in Japan